secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001372514-23-000053
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals dismisses EisnerAmper, appoints Haskell & White as auditor
--------------------------------------------------------------------------------

- Dismissed EisnerAmper effective March 24, 2023 after competitive bid process.
- No disagreements with EisnerAmper; material weakness in internal controls noted.
- Prior audit report included going concern explanatory paragraph.
- Appointed Haskell & White LLP as independent auditor for fiscal year 2023.
- No prior consultations with Haskell & White on accounting matters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000053/0001372514-23-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000053/kprx-20230324.htm
  HTML page:      https://secwatch.observer/filing/0001372514-23-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer